PT Merck Tbk (IDX:MERK)

Indonesia · Delayed Price · Currency is IDR

3,660.00

-90.00 (-2.40%)

Oct 12, 2026, 11:30 AM WIB

Market Cap	1.64T +30.7%
Revenue (ttm)	1.35T +29.2%
Net Income	333.16B +158.7%
EPS	743.66 +158.7%
Shares Out	448.00M
PE Ratio	5.04
Forward PE	n/a
Dividend	275.00 (7.51%)
Ex-Dividend Date	Jun 8, 2026

Volume	10,900
Open	3,750.00
Previous Close	3,750.00
Day's Range	3,640.00 - 3,750.00
52-Week Range	2,750.00 - 4,500.00
Beta	0.17
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About PT Merck Tbk

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, mult... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1970

Employees 358

Stock Exchange Indonesia Stock Exchange

Ticker Symbol MERK

Full Company Profile

Financial Performance

In 2025, PT Merck Tbk's revenue was 1.20 trillion, an increase of 15.81% compared to the previous year's 1.04 trillion. Earnings were 243.90 billion, an increase of 58.93%.

Financial Statements